Literature DB >> 8625162

Sensitivity of frozen section examination of pelvic lymph nodes for metastatic prostate carcinoma.

G L Davis1.   

Abstract

BACKGROUND: A Total Quality Improvement review of frozen section diagnoses yielded four sequential false-negative frozen section diagnoses in lymph nodes in the evaluation of metastases from prostate carcinoma. Because these results appeared to differ from the department's overall frozen section experience, frozen section diagnoses of pelvic lymph nodes in patients with prostate carcinoma were reviewed to benchmark the department's performance.
METHODS: All 220 pelvic lymph node frozen section samples from 110 patients with prostate carcinoma from January, 1986 to July, 1993 at Bridgeport Hospital (BH) were reviewed, and the department's frozen section diagnostic efficiency was compared with: (1) all BH frozen section procedures performed during the same period; (2) pelvic lymph node frozen section analysis and (3) imaging techniques for prostate carcinoma from other institutions found in MEDLARS literature searches from 1973 to 1993.
RESULTS: Frozen section diagnostic efficiency for patients with prostate carcinoma from BH was 93.6% (sensitivity 63.2%, specificity 100%) compared with (1) 98% for all BH frozen section analyses (sensitivity 99%, specificity 98%); (2) 90.1% for MEDLARS search pelvic lymph node frozen section prostate carcinoma analyses (sensitivity 66.5%, specificity 100%); and (3) 88% for MEDLARS search magnetic resonance imaging (MRI) pelvic lymph node prostate carcinoma (sensitivity 41%, specificity 97%).
CONCLUSIONS: Frozen section diagnosis of pelvic lymph nodes approaches the overall diagnostic efficiency of frozen section analysis and is more sensitive for the diagnosis of prostate carcinoma in pelvic lymph nodes than is MRI because more than half of the metastases are smaller than the 1.0-cm resolution limit of the MRI. False-negative frozen section diagnoses (67% sensitivity) occur because of errors in sampling microscopic metastases.

Entities:  

Mesh:

Year:  1995        PMID: 8625162     DOI: 10.1002/1097-0142(19950815)76:4<661::aid-cncr2820760419>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  Imaging and evaluation of patients with high-risk prostate cancer.

Authors:  Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

Review 2.  Contrast-enhanced MR imaging of lymph nodes in cancer patients.

Authors:  Seung Hong Choi; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

3.  Periprostatic schwannoma mimicking metastatic lymphadenopathy in a case of multifocal prostate adenocarcinoma.

Authors:  Jia Wei Tan; Jyothirmayi Velaga; John Shyi Ping Yuen; Xin Min Cheng; Yan Mee Law
Journal:  J Radiol Case Rep       Date:  2021-03-31

Review 4.  Lymphatic imaging: focus on imaging probes.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-03-18       Impact factor: 11.556

5.  Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging.

Authors:  Xiangyu Yang; Zhe Wang; Fuwu Zhang; Guizhi Zhu; Jibin Song; Gao-Jun Teng; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

Review 6.  Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer.

Authors:  Samuel J Galgano; Roberto Valentin; Jonathan McConathy
Journal:  Transl Androl Urol       Date:  2018-09

Review 7.  Lymph node imaging in initial staging of prostate cancer: An overview and update.

Authors:  Jessica G Zarzour; Sam Galgano; Jonathan McConathy; John V Thomas; Soroush Rais-Bahrami
Journal:  World J Radiol       Date:  2017-10-28

8.  Theragnostic Glycol Chitosan-Conjugated Gold Nanoparticles for Photoacoustic Imaging of Regional Lymph Nodes and Delivering Tumor Antigen to Lymph Nodes.

Authors:  In-Cheol Sun; SeongHoon Jo; Diego Dumani; Wan Su Yun; Hong Yeol Yoon; Dong-Kwon Lim; Cheol-Hee Ahn; Stanislav Emelianov; Kwangmeyung Kim
Journal:  Nanomaterials (Basel)       Date:  2021-06-28       Impact factor: 5.076

Review 9.  Surgical management of high-risk, localized prostate cancer.

Authors:  Lamont J Wilkins; Jeffrey J Tosoian; Debasish Sundi; Ashley E Ross; Dominic Grimberg; Eric A Klein; Brian F Chapin; Yaw A Nyame
Journal:  Nat Rev Urol       Date:  2020-11-10       Impact factor: 14.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.